These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis. Takao H, Nojo T, Ohtomo K. Acad Radiol; 2008 Apr; 15(4):462-71. PubMed ID: 18342771 [Abstract] [Full Text] [Related]
3. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Wermer MJ, Koffijberg H, van der Schaaf IC, ASTRA Study Group. Neurology; 2008 May 27; 70(22):2053-62. PubMed ID: 18420481 [Abstract] [Full Text] [Related]
10. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Xie F, Luo N, Blackhouse G, Goeree R, Lee HP. Int J Technol Assess Health Care; 2008 Jul 27; 24(1):87-95. PubMed ID: 18218173 [Abstract] [Full Text] [Related]
11. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group. N Engl J Med; 1999 Oct 28; 341(18):1344-50. PubMed ID: 10536126 [Abstract] [Full Text] [Related]
12. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines. Hayashino Y, Shimbo T, Tsujii S, Ishii H, Kondo H, Nakamura T, Nagata-Kobayashi S, Fukui T. Int J Cardiol; 2007 May 16; 118(1):88-96. PubMed ID: 16949690 [Abstract] [Full Text] [Related]
13. Cost-effectiveness of treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage. Takao H, Nojo T, Ohtomo K. Acad Radiol; 2008 Sep 16; 15(9):1126-32. PubMed ID: 18692753 [Abstract] [Full Text] [Related]